Featured News
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
Virginia Workforce Award to AMPEL BioSolutions
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Innovator-of-Year to AMPEL
COMPANY
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PLATFORM
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PRODUCTS
Local Company’s Blood Test Will Change Lupus Care
A local precision medicine and science company launched a test that will change the way lupus patients get care. AMPEL BioSolutions created a blood test called LuGENE. It will predict if someone is likely to have a lupus flare.
AMPEL BioSolutions Developing Molecular Test to Predict Kidney Damage in Lupus Nephritis Patients
According to the company, the test identifies molecular markers in kidney biopsy samples of LN patients, which can help reveal patients’ disease stage. This information, in turn, could help those pharmaceutical companies who have more than 45 LN drugs in development enroll patients in clinical trials with greater precision, AMPEL said.
This New Blood Test For Fibromyalgia Could Identify Your Best Treatment Options
Different from the FM/a blood test used for diagnosis, this new blood test for Fibromyalgia may be the key to your treatment plan.
New test to identify, treat kidney disease
CLICK TO READ ARTICLE & VIEW VIDEO > By Felicity Taylor CHARLOTTESVILLE, Va. (CBS19 NEWS) -- A local company says it has discovered a new way to identify and treat kidney disease. AMPEL BioSolutions is a precision medicine company that studies RNA and gene...
AMPEL BioSolutions’ Breakthrough Predicts Drug Options to Slow End Stage Renal Disease
CLICK TO VIEW ARTICLE > CHARLOTTESVILLE, Va., March 1, 2023 /PRNewswire/ -- AMPEL BioSolutions today announced a genomic precision medicine test for chronic kidney diseases, such as Lupus Nephritis, that could save lives by predicting kidney damage before it is...
Experimental Blood Test Could Improve Fibromyalgia Treatment
A small pilot study suggests an experimental blood test for fibromyalgia – called FibroGENE — could be used to determine which drug works best for each patient. Researchers at AMPEL BioSolutions and Duke University Medical Center found genetic biomarkers in the blood cells of 18 lupus patients with fibromyalgia-like symptoms.
PARTNERS
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The normalization effect of Krill Oil supplementation persisted through 48weeks during the open label extension. Importantly, Krill Oil appeared to decrease Lupus disease activity in patients who were sicker at baseline
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The ORKIDS clinical trial of Krill Oil supplementation for Lupus was a team effort that documented patients were uniformly omega-3 fatty acid deficient which was reversible with Krill Oil supplementation.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
“Our mission is to improve human health, and since inception we have prioritized scientific investigations through R&D to understand the nutritional value and potential health benefits of Krill Oil nutrients,
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The results indicate that Lupus patients have suboptimal omega-3 (measured in red blood cell membranes using the standard omega3 index) which was normalized by one month supplementation with Krill Oil.